Dividend / buyback / bonusMajor developmentFiled on BSE ·

Medi Assist H1 FY27 EBITDA up 19.0%; board approves buyback of up to ~₹49.3 Cr

Medi Assist Healthcare Services · Insurance

Arthneeti Research DeskPublished 1 min read
₹49.3 CrDividend / buyback / bonus

Key highlights

  • H1 FY27 operating revenue rose 13.0% YoY to ₹478.0 Cr; operating EBITDA grew 19.0% to ₹97.2 Cr, with margin up 103 bps to 20.3%.
  • Board approved a share buyback of up to ~₹49.3 Cr, funded entirely from internal operating cash flows, using less than a fifth of accumulated cash reserves.
  • Group health benefits market share reached 34.1% (+182 bps YoY); group premiums under management grew 21.8% YoY to ₹13,939 Cr in H1 FY27.

Why it's rated major development: the year-on-year change is 60% (50% or more)

Figures checked against the filing by a second AI read, which corrected the first summary. About the business, not the share price.

Original filing

Announcement under Regulation 30 (LODR)-Press Release / Media Release

Read the filing on BSE (PDF) →

Companies guiding to strong growth

Ranked by management's own guidance on revenue and margins — not by us.

Waaree Energies Ltd

Electrical Equipment

Revenue growth 40%+Margin up 2%+

Sign up free to see all 6 →

See full rankings

Rank buckets describe management commentary on revenue and margin. Not investment advice, and not a forecast of returns.

More from Medi Assist Healthcare Services

Other dividend / buyback / bonus filings this fortnight

All dividend / buyback / bonus filings →

Summary written by Arthneeti from the company's filing with the stock exchange; check the original filing for full details. Arthneeti is a research and analytics platform, not a SEBI-registered investment adviser, and nothing here is a recommendation to buy or sell.